74 related articles for article (PubMed ID: 8945598)
1. Mutants of the Escherichia coli heat-labile enterotoxin with reduced ADP-ribosylation activity or no activity retain the immunogenic properties of the native holotoxin.
de Haan L; Verweij WR; Feil IK; Lijnema TH; Hol WG; Agsteribbe E; Wilschut J
Infect Immun; 1996 Dec; 64(12):5413-6. PubMed ID: 8945598
[TBL] [Abstract][Full Text] [Related]
2. Role of GM1 binding in the mucosal immunogenicity and adjuvant activity of the Escherichia coli heat-labile enterotoxin and its B subunit.
de Haan L; Verweij WR; Feil IK; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
Immunology; 1998 Jul; 94(3):424-30. PubMed ID: 9767427
[TBL] [Abstract][Full Text] [Related]
3. Mucosal immunogenicity and adjuvant activity of the recombinant A subunit of the Escherichia coli heat-labile enterotoxin.
De Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
Immunology; 1999 Aug; 97(4):706-13. PubMed ID: 10457227
[TBL] [Abstract][Full Text] [Related]
4. Mutational analysis of the role of ADP-ribosylation activity and GM1-binding activity in the adjuvant properties of the Escherichia coli heat-labile enterotoxin towards intranasally administered keyhole limpet hemocyanin.
de Haan L; Feil IK; Verweij WR; Holtrop M; Hol WG; Agsteribbe E; Wilschut J
Eur J Immunol; 1998 Apr; 28(4):1243-50. PubMed ID: 9565364
[TBL] [Abstract][Full Text] [Related]
5. Mucosal immunogenicity of the Escherichia coli heat-labile enterotoxin: role of the A subunit.
de Haan L; Holtrop M; Verweij WR; Agsteribbe E; Wilschut J
Vaccine; 1996 Mar; 14(4):260-6. PubMed ID: 8744549
[TBL] [Abstract][Full Text] [Related]
6. Both LTA and LTB Subunits Are Equally Important to Heat-Labile Enterotoxin (LT)-Enhanced Bacterial Adherence.
Duan Q; Pang S; Feng L; Li B; Lv L; Liang Y; Zhu G
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674760
[TBL] [Abstract][Full Text] [Related]
7. Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity.
Giuliani MM; Del Giudice G; Giannelli V; Dougan G; Douce G; Rappuoli R; Pizza M
J Exp Med; 1998 Apr; 187(7):1123-32. PubMed ID: 9529328
[TBL] [Abstract][Full Text] [Related]
8. NAD-dependent ADP-ribosylation of arginine and proteins by Escherichia coli heat-labile enterotoxin.
Moss J; Garrison S; Oppenheimer NJ; Richardson SH
J Biol Chem; 1979 Jul; 254(14):6270-2. PubMed ID: 221495
[TBL] [Abstract][Full Text] [Related]
9. The Escherichia coli heat labile toxin binds to Golgi membranes and alters Golgi and cell morphologies using ADP-ribosylation factor-dependent processes.
Zhu X; Kahn RA
J Biol Chem; 2001 Jul; 276(27):25014-21. PubMed ID: 11333260
[TBL] [Abstract][Full Text] [Related]
10. Effects of intranasal administration of cholera toxin (or Escherichia coli heat-labile enterotoxin) B subunits supplemented with a trace amount of the holotoxin on the brain.
Hagiwara Y; Iwasaki T; Asanuma H; Sato Y; Sata T; Aizawa C; Kurata T; Tamura S
Vaccine; 2001 Feb; 19(13-14):1652-60. PubMed ID: 11166888
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the A subunit affect yield, stability, and protease sensitivity of nontoxic derivatives of heat-labile enterotoxin.
Magagnoli C; Manetti R; Fontana MR; Giannelli V; Giuliani MM; Rappuoli R; Pizza M
Infect Immun; 1996 Dec; 64(12):5434-8. PubMed ID: 8945604
[TBL] [Abstract][Full Text] [Related]
12. Activation of adenylate cyclase by heat-labile Escherichia coli enterotoxin. Evidence for ADP-ribosyltransferase activity similar to that of choleragen.
Moss J; Richardson SH
J Clin Invest; 1978 Aug; 62(2):281-5. PubMed ID: 209060
[TBL] [Abstract][Full Text] [Related]
13. Recombinant adenovirus carrying a core neutralizing epitope of porcine epidemic diarrhea virus and heat-labile enterotoxin B of Escherichia coli as a mucosal vaccine.
Do VT; Jang J; Park J; Dao HT; Kim K; Hahn TW
Arch Virol; 2020 Mar; 165(3):609-618. PubMed ID: 31950289
[TBL] [Abstract][Full Text] [Related]
14. Isolation and characterization of enterotoxin-deficient mutants of Escherichia coli.
Silva ML; Maas WK; Gyles CL
Proc Natl Acad Sci U S A; 1978 Mar; 75(3):1384-8. PubMed ID: 349567
[TBL] [Abstract][Full Text] [Related]
15. Direct serological assay for the heat-labile enterotoxin of Escherichia coli, using passive immune hemolysis.
Evans DJ; Evans DG
Infect Immun; 1977 May; 16(2):604-9. PubMed ID: 193793
[TBL] [Abstract][Full Text] [Related]
16. Type II heat-labile enterotoxins: structure, function, and immunomodulatory properties.
Hajishengallis G; Connell TD
Vet Immunol Immunopathol; 2013 Mar; 152(1-2):68-77. PubMed ID: 23137790
[TBL] [Abstract][Full Text] [Related]
17. M cell-targeted mucosal vaccine strategies.
Yamamoto M; Pascual DW; Kiyono H
Curr Top Microbiol Immunol; 2012; 354():39-52. PubMed ID: 21688209
[TBL] [Abstract][Full Text] [Related]
18. Identification of an iron-sulfur cluster that modulates the enzymatic activity in NarE, a Neisseria meningitidis ADP-ribosyltransferase.
Del Vecchio M; Pogni R; Baratto MC; Nobbs A; Rappuoli R; Pizza M; Balducci E
J Biol Chem; 2009 Nov; 284(48):33040-7. PubMed ID: 19744927
[TBL] [Abstract][Full Text] [Related]
19. Dendritic cell-targeting DNA-based mucosal adjuvants for the development of mucosal vaccines.
Kataoka K; Fujihashi K
Expert Rev Vaccines; 2009 Sep; 8(9):1183-93. PubMed ID: 19722892
[TBL] [Abstract][Full Text] [Related]
20. Secretory expression and purification of recombinant Escherichia coli heat-labile enterotoxin B subunit and its applications on intranasal vaccination of hantavirus.
Cao S; Zhang Y; Liu F; Wang Q; Zhang Q; Liu Q; Li C; Liang M; Li D
Mol Biotechnol; 2009 Feb; 41(2):91-8. PubMed ID: 19089660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
